Jpmorgan Chase & CO Bridge Bio Pharma, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 299,214 shares of BBIO stock, worth $10 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,214

Previous 1,216,116 75.4%

Holding current value

$10 Million

Previous $31 Million 73.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$22.35 - $29.5 $20.5 Million - $27 Million	-916,902 Reduced 75.4%	299,214 $8.21 Million
Q3 2024 Dec 26, 2024	BUY	$23.91 - $31.3 $24.9 Million - $32.6 Million	1,040,037 Added 590.66%	1,216,116 $31 Million
Q3 2024 Nov 08, 2024	BUY	$23.91 - $31.3 $24.9 Million - $32.6 Million	1,040,037 Added 590.66%	1,216,116 $31 Million
Q2 2024 Dec 26, 2024	SELL	$23.0 - $31.04 $23.9 Million - $32.3 Million	-1,040,037 Reduced 85.52%	176,079 $4.46 Million
Q2 2024 Aug 12, 2024	SELL	$23.0 - $31.04 $4.38 Million - $5.92 Million	-190,574 Reduced 51.98%	176,079 $4.46 Million
Q1 2024 Dec 26, 2024	SELL	$27.35 - $40.45 $23.2 Million - $34.4 Million	-849,463 Reduced 69.85%	366,653 $11.3 Million
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $4.01 Million - $5.94 Million	146,734 Added 66.72%	366,653 $11.3 Million
Q4 2023 Dec 26, 2024	SELL	$24.02 - $43.89 $23.9 Million - $43.7 Million	-996,197 Reduced 81.92%	219,919 $8.88 Million
Q4 2023 Feb 12, 2024	BUY	$24.02 - $43.89 $140,517 - $256,756	5,850 Added 2.73%	219,919 $8.88 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $203,828 - $422,500	-12,068 Reduced 5.34%	214,069 $5.64 Million
Q2 2023 Aug 11, 2023	SELL	$13.29 - $18.01 $1.46 Million - $1.99 Million	-110,231 Reduced 32.77%	226,137 $3.89 Million
Q1 2023 May 18, 2023	BUY	$7.17 - $18.55 $992,930 - $2.57 Million	138,484 Added 69.98%	336,368 $5.58 Million
Q1 2023 May 11, 2023	SELL	$7.17 - $18.55 $2.37 Million - $6.14 Million	-331,241 Reduced 62.6%	197,884 $3.28 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $1.61 Million - $2.75 Million	238,841 Added 82.28%	529,125 $4.03 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $744,740 - $1.16 Million	-93,796 Reduced 24.42%	290,284 $2.89 Million
Q2 2022 Aug 11, 2022	SELL	$5.21 - $12.14 $1.9 Million - $4.42 Million	-364,026 Reduced 48.66%	384,080 $3.49 Million
Q1 2022 May 11, 2022	SELL	$7.34 - $17.16 $5.83 Million - $13.6 Million	-794,597 Reduced 51.51%	748,106 $7.59 Million
Q4 2021 Feb 10, 2022	BUY	$11.38 - $53.41 $1.01 Million - $4.73 Million	88,515 Added 6.09%	1,542,703 $25.7 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $68.2 Million - $93.4 Million	1,454,188 New	1,454,188 $68.2 Million

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.97B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bridge Bio Pharma, Inc. Transaction History